Abstract:Abstract Background Mesenchymal stromal cells in the endosteal niche lining compact bone (CB-MSCs) represent a heterogeneous population, all of which contribute to bone repair and remodelling. Hyperglycaemia associated with type 2 diabetes mellitus (T2DM) can delay and impair the bone healing process. Therefore, this study investigated the influences of high (25 mM) glucose conditions on CB-MSC populations isolated from male Wistar rats, versus normal (5.5 mM) glucose conditions; in terms of proliferation (population doublings, PDs), senescence characteristics, stem cell marker expression, colony forming efficiencies (CFEs); and osteogenic/adipogenic differentiation, following extended culture in vitro. Results CB-MSCs under both normoglycaemic and hyperglycaemic conditions demonstrated similar morphologies and rapid exponential growth to >300PDs, although high glucose conditions promoted more rapid and persistent proliferation beyond ~50PDs, with few indications of senescence. Limited senescence was confirmed by minimal SA-β-galactosidase staining, low senescence marker (p53, p21 waf1 , p16 INK4a ) expression and positive telomere maintenance marker (rTERT, TR) expression. However, telomere lengths varied throughout culture expansion, with hyperglycaemia significantly reducing telomere lengths at PD50 and PD200. Furthermore, CB-MSCs expanded in normal and high glucose conditions remained non-transformed, exhibiting similar MSC (CD73/CD90/CD105), multipotency (CD146) and embryonic (Slug, Snail) markers throughout extended culture, but negligible hematopoietic (CD34/CD45) or pluripotency (Nanog, Oct4) markers. Hyperglycaemia significantly increased CFEs at PD50 and PD100, which decreased at PD200. CB-MSC osteogenic differentiation was also inhibited by hyperglycaemia at PD15, PD100 and PD200, but not at PD50. Hyperglycaemia inhibited CB-MSC adipogenic differentiation to a lesser extent at PD15 and PD50, with reduced adipogenesis overall at PD100 and PD200. Conclusion This study demonstrates the limited negative impact of hyperglycaemia on the proliferative and stem cell characteristics of heterogeneous CB-MSC populations, although minor sub-population(s) appear more susceptible to these conditions leading to impaired osteogenic/adipogenic differentiation capabilities. Such findings potentially highlight the impact of hyperglycaemia on CB-MSC bone repair capabilities in situ.

Hyperglycemia impairs osteoblast cell migration and chemotaxis due to a decrease in mitochondrial biogenesis

High glucose-induced inhibition of osteoblast like MC3T3-E1 differentiation promotes mitochondrial perturbations

High Glucose Conditions Suppress the Function of Bone Marrow-Derived Endothelial Progenitor Cells Via Inhibition of the Enos-Caveolin-1 Complex.

Hyperglycemia Induces Endoplasmic Reticulum Stress-Dependent CHOP Expression in Osteoblasts

Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro

Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic male mice

Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia

Regulation of Glucose Handling by the Skeleton: Insights from Mouse and Human Studies

Diabetes impairs fracture healing through disruption of cilia formation in osteoblasts

Diabetes, bone and glucose-lowering agents: basic biology

Bone metabolism in diabetes: a clinician's guide to understanding the bone–glucose interplay

Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes

Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia

The Inhibition of PINK1/Drp1-mediated Mitophagy by Hyperglycemia Leads to Impaired Osteoblastogenesis in Diabetes

Effects of high glucose conditions on the expansion and differentiation capabilities of mesenchymal stromal cells derived from rat endosteal niche

Genetic activation of glycolysis in osteoblasts preserves bone mass in type I diabetes

Hyperglycemic microenvironment compromises the homeostasis of communication between the bone-brain axis by the epigenetic repression of the osteocalcin receptor, Gpr158 in the hippocampus

Type 1 Diabetes and Osteoporosis: From Molecular Pathways to Bone Phenotype

The Role of Wnt Signaling in Diabetes-Induced Osteoporosis

The Effect of Diabetes on the Bone Metabolism

Bone disorders associated with diabetes mellitus and its treatments